Tokio Marine Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.58M | Buy |
4,141
+216
| +6% | +$147K | 0.08% | 203 |
|
|
2026
Q1 | $3.03M | Buy |
3,925
+54
| +1% | +$41.3K | 0.11% | 159 |
|
|
2025
Q4 | $2.99M | Buy |
3,871
+38
| +1% | +$25.8K | 0.1% | 152 |
|
|
2025
Q3 | $2.16M | Buy |
3,833
+119
| +3% | +$67.3K | 0.08% | 204 |
|
|
2025
Q2 | $1.95M | Sell |
3,714
-11,348
| -75% | -$6.33M | 0.07% | 208 |
|
|
2025
Q1 | $9.55M | Buy |
15,062
+2,805
| +23% | +$1.93M | 0.35% | 60 |
|
|
2024
Q4 | $8.73M | Buy |
12,257
+9,030
| +280% | +$7.58M | 0.31% | 67 |
|
|
2024
Q3 | $3.39M | Buy |
3,227
+206
| +7% | +$229K | 0.15% | 109 |
|
|
2024
Q2 | $3.18M | Buy |
3,021
+338
| +13% | +$328K | 0.15% | 104 |
|
|
2024
Q1 | $2.58M | Buy |
2,683
+263
| +11% | +$250K | 0.13% | 122 |
|
|
2023
Q4 | $2.13M | Buy |
2,420
+81
| +3% | +$66.7K | 0.12% | 134 |
|
|
2023
Q3 | $1.92M | Buy |
2,339
+186
| +9% | +$146K | 0.12% | 124 |
|
|
2023
Q2 | $1.55M | Buy |
2,153
+98
| +5% | +$75.6K | 0.1% | 141 |
|
|
2023
Q1 | $1.69M | Buy |
2,055
+247
| +14% | +$186K | 0.12% | 134 |
|
|
2022
Q4 | $1.3M | Buy |
1,808
+168
| +10% | +$124K | 0.1% | 155 |
|
|
2022
Q3 | $1.13M | Buy |
1,640
+246
| +18% | +$155K | 0.1% | 150 |
|
|
2022
Q2 | $824K | Buy |
1,394
+195
| +16% | +$127K | 0.07% | 180 |
|
|
2022
Q1 | $837K | Sell |
1,199
-412
| -26% | -$261K | 0.07% | 178 |
|
|
2021
Q4 | $1.02M | Buy |
1,611
+99
| +7% | +$60.9K | 0.08% | 154 |
|
|
2021
Q3 | $915K | Buy |
1,512
+548
| +57% | +$340K | 0.08% | 155 |
|
|
2021
Q2 | $538K | Buy |
964
+216
| +29% | +$109K | 0.05% | 202 |
|
|
2021
Q1 | $354K | Sell |
748
-1,709
| -70% | -$832K | 0.04% | 246 |
|
|
2020
Q4 | $1.19M | Buy |
2,457
+381
| +18% | +$206K | 0.13% | 88 |
|
|
2020
Q3 | $1.16M | Buy |
2,076
+678
| +48% | +$411K | 0.14% | 77 |
|
|
2020
Q2 | $872K | Buy |
+1,398
| New | +$794K | 0.12% | 86 |
|
|
2017
Q4 | – | Sell |
-676
| Closed | -$302K | – | 336 |
|
|
2017
Q3 | $302K | Sell |
676
-223
| -25% | -$106K | 0.05% | 267 |
|
|
2017
Q2 | $442K | Sell |
899
-347
| -28% | -$152K | 0.06% | 228 |
|
|
2017
Q1 | $483K | Sell |
1,246
-332
| -21% | -$123K | 0.06% | 238 |
|
|
2016
Q4 | $579K | Sell |
1,578
-580
| -27% | -$221K | 0.07% | 192 |
|
|
2016
Q3 | $868K | Sell |
2,158
-193
| -8% | -$77.4K | 0.09% | 174 |
|
|
2016
Q2 | $821K | Sell |
2,351
-84
| -3% | -$32.4K | 0.08% | 190 |
|
|
2016
Q1 | $878K | Buy |
2,435
+106
| +5% | +$43.7K | 0.09% | 186 |
|
|
2015
Q4 | $1.26M | Sell |
2,329
-209
| -8% | -$113K | 0.14% | 145 |
|
|
2015
Q3 | $1.18M | Sell |
2,538
-14
| -0.5% | -$7.52K | 0.12% | 150 |
|
|
2015
Q2 | $1.3M | Sell |
2,552
-670
| -21% | -$327K | 0.13% | 151 |
|
|
2015
Q1 | $1.46M | Sell |
3,222
-506
| -14% | -$214K | 0.13% | 145 |
|
|
2014
Q4 | $1.53M | Sell |
3,728
-1,174
| -24% | -$462K | 0.13% | 162 |
|
|
2014
Q3 | $1.77M | Sell |
4,902
-396
| -7% | -$133K | 0.13% | 180 |
|
|
2014
Q2 | $1.5M | Hold |
5,298
| – | – | 0.1% | 210 |
|
|
2014
Q1 | $1.59M | Buy |
5,298
+616
| +13% | +$190K | 0.1% | 195 |
|
|
2013
Q4 | $1.29M | Hold |
4,682
| – | – | 0.08% | 248 |
|
|
2013
Q3 | $1.47M | Hold |
4,682
| – | – | 0.09% | 217 |
|
|
2013
Q2 | $1.05M | Buy |
+4,682
| New | +$1.09M | 0.07% | 306 |
|
Other funds holding REGN
Tokio Marine Asset Management's REGN Position: Q2 2026 in Review
Tokio Marine Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 5.5% in Q2 2026, buying an estimated $147K and bringing the position to 4,141 shares worth $2.58M. The position accounts for 0.08% of the portfolio, ranked #203.
Tokio Marine Asset Management first reported a position in REGN in Q2 2013 and has held it in 43 quarters since. The position peaked at $9.55M in Q1 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Tokio Marine Asset Management held 4,141 shares of Regeneron Pharmaceuticals worth $2.58M as of Q2 2026.
- Tokio Marine Asset Management bought 216 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $147K.
- Regeneron Pharmaceuticals made up 0.08% of Tokio Marine Asset Management's portfolio in Q2 2026, its #203 holding.
- Tokio Marine Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 43 quarters since.
- Tokio Marine Asset Management's Regeneron Pharmaceuticals position peaked at $9.55M in Q1 2025.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.